Paige, OptraScan partner to push digital pathology adoption

By staff writers

September 22, 2022 -- Paige on Thursday announced a partnership with OptraScan to streamline digital pathology technology adoption in the U.S., EU, and U.K.

The companies aim to reduce barriers to the adoption of digitizing glass pathology slides, which will in turn enhance workflows in pathology and oncology, Paige said.

"This collaboration is an important step in our mission to unlock the full potential of [artificial intelligence (AI)] in routine clinical use and provide healthcare professionals with precise insights to help patients get the most effective care," Andy Moye, CEO of Paige, said in a statement.

Together, the companies will integrate Paige's clinical artificial intelligence applications and interoperable enterprise imaging platform with OptraScan's digital pathology scanner to enable end-to-end digital pathology workflow solutions.

Paige, Sonora Quest partner on digital pathology in Arizona
Paige and Sonora Quest Laboratories announced on Thursday that they have formed a partnership to implement a digital pathology workflow in Sonora Quest’s...
Paige, Janssen collaborating on AI-based bladder cancer test
Paige on Wednesday announced a collaboration with Janssen Research & Development to evaluate the potential of a hematoxylin and eosin (H&E) and artificial...
OptraScan wins patent for digital pathology AI technology
OptraScan has received a U.S. patent for technology on its OS-SiA digital pathology scanner, which is able to scan, index, and analyze pathological samples...
Paige gets nod in Europe for prostate biomarker suite
Artificial intelligence (AI) developer Paige has received CE-in vitro diagnostic and U.K. Conformity Assessed marks for its Paige Prostate Biomarker Suite.
OptraScan launches cytology slide scanning device
OptraScan has released a new device called CytoSiA for scanning and analyzing liquid-based cytology slides and Pap smears.

Copyright © 2022

Last Updated mp 9/22/2022 11:46:15 AM